Arterial Thrombosis in Severe Ulcerative Colitis: A Case-Based Narrative Review of Current Evidence. [PDF]
Kralj D +12 more
europepmc +1 more source
Emerging therapeutic pipelines on kidney fibrosis: challenges in translational research. [PDF]
Granata S +8 more
europepmc +1 more source
An ST elevation myocardial infarction with multisystemic embolization: a shocking and striking first presentation of antiphospholipid syndrome: a case report. [PDF]
Haboub M, Atlas I, Drighil A, Habbal R.
europepmc +1 more source
Effects of B Vitamins on Homocysteine Lowering and Thrombotic Risk Reduction-A Review of Randomized Controlled Trials Published Since January 1996. [PDF]
Li M +7 more
europepmc +1 more source
P2 Receptor Antagonists Rescue Defective Heme Content in an In Vitro SLC25A38-Associated Congenital Sideroblastic Anemia Cell Model. [PDF]
Santoro A +16 more
europepmc +1 more source
Preparation of Lipophilic Derivatives of <i>para</i>-Aminosalicylic Acid for Antimicrobial Drug Design. [PDF]
Hearn MJ, Min AK.
europepmc +1 more source
Since the protective effect of folic acid (FA) on birth defects is well known, it is reasonable to assume intrauterine exposure to FA antagonists increases the risk on these defects. We have therefore performed case-control analyses to investigate the risk of intrauterine exposure to FA antagonists, using data on births from the EUROCAT Northern ...
Willemijn M Meijer +2 more
exaly +4 more sources
Related searches:
Risk of Fetal Exposure to Folic Acid Antagonists
Journal of Obstetrics and Gynaecology Canada, 2004Several folic acid antagonists are considered by the Food and Drug Administration (FDA) to be toxic or potentially toxic to fetuses, including some folic acid antagonists that were once considered safe, such as trimethoprim. Information on fetal exposure to folic acid antagonists is sparse.In this study, we conducted a thorough search of English ...
Shi Wu Wen Mb
exaly +3 more sources

